Rafferty Asset Management, LLC Esperion Therapeutics, Inc. Transaction History
Rafferty Asset Management, LLC
- $29.7 Billion
- Q3 2025
A detailed history of Rafferty Asset Management, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 28,251 shares of ESPR stock, worth $83,057. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,251Holding current value
$83,057% of portfolio
0.0%Shares
18 transactions
Others Institutions Holding ESPR
# of Institutions
190Shares Held
114MCall Options Held
144KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$41.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$35.6 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$30.4 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$29.3 Million0.18% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.6 Million4.26% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $196M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...